Enabling Faster Drug Discovery in the Cloud

Cryo-EM has emerged as a powerful tool for enabling rapid advances in drug discovery. The scale, simplicity, and economics of AWS promises to transform cryo-EM workflows even further. However, processing and analyzing large cryo-EM datasets in AWS requires the right architecture and the right data platform. Join this chat with Baris Guler, HPC Practice Manager at Clovertex to learn: - How cryo-EM is impacting drug discovery and the main challenges that exist. - Why traditional storage approaches aren’t meeting the demands of cryo-EM applications like CryoSPARC. - How they leverage WEKA with AWS to enable faster drug discovery workflows. - What benchmarks they have seen and recommendations you can use.